|
⚲
|
| Keyboard |
| Menzel Garry E
✚
|
|
|---|---|
| CIK # | 0001556064 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001556064] | |
| 4 | [0001556064] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Menzel Garry E | |
| Black Diamond Therapeutics Inc | |
| Stoke Therapeutics Inc | |
| Adaptimmune Therapeutics PLC | |
| TCR2 Therapeutics Inc | |
| Davita Inc | |
| Regulus Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Black Diamond Therapeutics Inc BDTX
Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 30,550 | $0.00 | |
|
Stoke Therapeutics Inc STOK
Director Stock Option (Right to Buy) · derivative
|
2025-06-03 | Grant | 29,747 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2024-07-01 | Grant | 1,121,604 | $0.00 | |
|
Black Diamond Therapeutics Inc BDTX
Stock Option (Right to Buy) · derivative
|
2024-06-06 | Grant | 30,550 | $0.00 | |
|
Stoke Therapeutics Inc STOK
Director Stock Option (Right to Buy) · derivative
|
2024-06-05 | Grant | 7,639 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
American Depositary Shares representing Ordinary Shares
|
2023-07-10 | Sell | 47,702 | $0.91 | 43,409 |
|
Adaptimmune Therapeutics PLC ADAP
Option to Purchase Ordinary Shares · derivative
|
2023-07-05 | Grant | 2,715,816 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to Purchase Ordinary Shares · derivative
|
2023-07-05 | Grant | 57,846 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to Purchase Ordinary Shares · derivative
|
2023-07-05 | Grant | 3,568,026 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to Purchase Ordinary Shares · derivative
|
2023-07-05 | Grant | 359,700 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to Purchase Ordinary Shares · derivative
|
2023-07-05 | Grant | 736,548 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to Purchase Ordinary Shares · derivative
|
2023-07-05 | Grant | 2,158,776 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to Purchase Ordinary Shares · derivative
|
2023-07-05 | Grant | 1,251,966 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2023-07-03 | Grant | 981,463 | $0.00 | |
|
Stoke Therapeutics Inc STOK
Director Stock Option (Right to Buy) · derivative
|
2023-06-13 | Grant | 19,441 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
American Depositary Shares representing Ordinary Shares
|
2023-06-01 | Grant | 200,647 | ||
|
Adaptimmune Therapeutics PLC ADAP
American Depositary Shares representing Ordinary Shares
|
2023-06-01 | Grant | 209,931 | ||
|
Adaptimmune Therapeutics PLC ADAP
American Depositary Shares representing Ordinary Shares
|
2023-06-01 | Grant | 200,646 | ||
|
TCR2 Therapeutics Inc TCRR
Common Stock
|
2023-06-01 | Disposed to issuer | 132,730 | ||
|
TCR2 Therapeutics Inc TCRR
Common Stock
|
2023-06-01 | Disposed to issuer | 138,871 | ||
| showing 20 of 85 most recent transactions | |||||